Simepar-Acino
Simepar-Acino is a medicine authorised by Swissmedic under authorisation number 38625. The authorisation holder is Acino Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 December 1976 and the authorisation is valid without a time limit. ATC code A05BA03 places the medicine in the group Bile and liver therapy.
| Authorisation number | 38625 |
|---|---|
| Name | Simepar-Acino |
| Full name | Simepar-Acino, Kapseln |
| Authorisation holder | Acino Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A05BA03 |
| First authorisation | 10 December 1976 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Simepar-Acino, Kapseln | B | 10 December 1976 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 40 | Kapsel(n) | A05BA03 | 04.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Simepar-Acino authorised in Switzerland?
Yes. Simepar-Acino is authorised by Swissmedic under authorisation number 38625, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Simepar-Acino have?
Simepar-Acino is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Simepar-Acino?
The authorisation holder is Acino Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.